Overview

NAM-Trial: Multiferon in Malignant Melanoma

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

The current clinical trial shall clarify the efficacy, safety and biologic effects of neoadjuvant treatment with natural interferon-α (Multiferon) in patients with locoregional metastases of melanoma in stage IIIB/C.

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital Tuebingen

Treatments:

Interferons